A) Zyprexa B) Geodon C) Risperdal D) Prolixin
A) Clozaril B) Invega C) Abilify D) Zyprexa
A) Invega B) Seroquel C) Zyprexa D) Abilify
A) Zyprexa B) Abilify C) Seroquel D) Risperdal
A) Seroquel B) Geodon C) Abilify D) Risperdal
A) Clozapine B) Quetiapine C) Ziprasidone D) Olanzapine
A) Paliperidone B) Risperidone C) Ziprasidone D) Aripriprazole
A) Clozaril B) Geodon C) Seroquel D) Risperdal
A) Paliperidone B) Ziprasidone C) Aripiprazole D) Clozapine
A) Quetiapine B) Paliperidone C) Risperdone D) Olazapine
A) Risperidone and Paliperidone B) Aripiprazole and Paliperidone C) Clozapine and Aripiprazole D) Clozapine and Risperadone
A) 1 B) 2-5 C) 4-5 D) 1-3
A) 6 B) 12 C) 24 D) 18
A) FALSE B) TRUE
A) Develop more adaptive coping skills B) Foster patients' medication compliance C) Prevent relapse into another psychotic episode D) Minimize side effects of medication
A) several weeks after discontinuation of medication B) six months after discontinuation of medication C) directly after discontinuation of medication D) one year after discontinuation of medication
A) Clozaril B) Symmetrel C) Artane D) Thorazine
A) tardive dyskinesia more common B) increased effectiveness for positive, negative, and disorganized symptoms C) weight gain more common D) enhanced efficacy in treatment-resistant patients
A) Clozapine B) Haloperiodol C) Prochlorperazine D) Risperidone
A) Stimulants B) Anxiolitics C) Anticonvulsants D) Alcohol
A) Alcohol B) Merperidine C) Halperiodol D) Beta blockers
A) Nicotine B) Anticonvulsants C) Beta blockers D) Antacids
A) Beta blockers B) SSRIs C) Alcohol D) Tricyclic antidepressants
A) TRUE B) FALSE
A) Alcohol use B) Tobacco use C) Drug holidays D) Male gender
A) TRUE B) FALSE
A) All antipsychotic drugs but Clozapine present a significant risk for the development of tardive dyskinesia. B) The more frequent the dose of the antipsychotic medication, the greater the risk for the development of tardive dyskinesia. C) High potency antipsychotic drugs present greater risk for the development of tardive dyskinesia. D) Classic antipsychotic medications present less risk for the development of tardive dyskinesia than atypical antipsychotic medications.
A) Ataxia B) Akathesia C) Acute dystonia D) Akinesia
A) Agranulocytosis B) Postural hypotension C) Gynecomastia D) Neuroleptic Malignant Syndrome
A) TRUE B) FALSE
A) TRUE B) FALSE
A) agonize the normal dopamine-mediated inhibition of prolactin release. B) antagonize the normal dopamine-mediated inhibition of prolactin release. C) block D2 receptors in the pituitary gland and decrease prolactin secretion. D) block D2 receptors in the pituitary gland and inhibit prolactin secretion.
A) hungry hungry hippos B) receptor binding and DA turnover C) neuroendocrine changes D) molecular structure
A) Thioxanthenenes B) Butyrophenones C) Phenothiazines D) Sleepykoaladones
A) Weak; high; higher B) Potent; low; lower C) Potent; low; higher D) Weak; high; lower
A) Delusions B) Anhedonia C) Hallucinations D) Formal thought disorder
A) Neurological disorders B) Autoimmune diseases C) Endocrine disorders D) All of the above E) Metabolic disorders
A) Opioids B) All of the above C) Stimulants D) Hallucinogens E) Alcohol
A) TRUE B) FALSE
A) disorganized symptoms of Schizophrenia. B) negative symptoms of Schizophrenia. C) All of the above. D) positive symptoms of Schizophrenia.
A) blocking post-synaptic dopamine receptors and/or inhibiting dopamine release. B) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine release. C) blocking post-synaptic dopamine receptors and/or inhibiting dopamine reuptake. D) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine reuptake.
A) the drug increases the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine. B) the drug reduces the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine. C) the drug reduces the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine. D) the drug increases the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine.
A) increased rates of synthesis B) increased release of dopamine C) increased rates of firing D) increased tap dancing
A) thioxanthenes B) piperideines C) piperazines D) aliphatics
A) genecomastia B) all of the above C) menstrual irregularity D) galactorrhea
A) Inapsine (droperiodol) B) Symmetrel (amantadine) C) Benadryl (diphenhydramine) D) Cogentin (benztropine) E) Artane (trihexphenidyl)
A) FALSE B) TRUE
A) polypharmacy B) comparative lack of EPS C) superior impact on positive symptoms D) actual impact at the biological level
A) Invega B) Haldol C) Clozaril D) Abilify
A) Clorazil B) Risperdal C) Geodon D) Seroquel |